CMChinaMNC

Published by ChinaMNC · Zhoukou

China's Health-Sector Priorities for the 15th Five-Year Plan: What Foreign Founders Should Know

A guide for foreign founders on China's health and wellness policy direction for the 15th Five-Year Plan period, based on the national health conference held in Beijing, and what it could mean for company registration and operations in China.

China Signals Health-Sector Direction for the 15th Five-Year Plan Period

At a national health conference held in Beijing on 12–13 October, China's leadership set out the broad direction for the health and wellness sector during the 15th Five-Year Plan period, which officials described as a critical window for achieving the goal of building a "Healthy China" by 2035. President Xi Jinping delivered the keynote address, and Premier Li Qiang gave a concluding speech. Senior leaders Zhao Leji, Wang Huning, Cai Qi, Ding Xuexiang and Li Xi also attended.

For foreign founders evaluating China as a market — particularly in healthcare services, medical devices, pharmaceuticals, wellness, food safety and related technology — the conference is a useful signal of where policy attention and public investment are likely to concentrate. Below is a practical summary of the points raised, with an eye to what they may mean for registering and operating a company in China.

Stated Achievements and the Policy Baseline

Xi noted that since the 18th Party Congress, the leadership has treated protection of public health as a strategic priority, established a health work policy for the new era, and made major decisions on building a Healthy China. According to the source, China has built the world's largest systems for medical services, traditional medicine, disease prevention and control, and medical insurance. The conference described these as historic achievements and all-round progress.

For founders, this framing matters because it indicates that the regulatory and institutional architecture around healthcare is mature and extensive. Entry routes, licensing and compliance expectations are likely to be well defined — but also detailed. Early legal and regulatory due diligence remains essential.

The Stated Vision: What a "Healthy China" Should Look Like

Xi described the intended Healthy China as balanced, inclusive, high-quality and efficient, with strong capabilities in:

The stated aim is to meet growing public demand for health services while steadily improving major health indicators. Foreign founders in medtech, digital health, diagnostics and pharmaceutical R&D may see alignment opportunities here, though the source does not specify market-opening measures or procurement guarantees.

Health Priorities as a Cross-Cutting Policy Principle

The conference stressed that health work has a foundational, economy-wide role and that a "health first" development strategy must be firmly implemented. Health protection is to be integrated into all policies and reflected across government work — including planning, policy design, project appraisal and construction. In practical terms, this suggests that health impact considerations may increasingly appear in project approvals and policy reviews. Founders in food, chemicals, construction and consumer products should note this cross-cutting principle when planning China operations.

Prevention, Food Safety and Public Health

Xi called prevention the most economical and effective health strategy, emphasizing foundational and source-level work. Specific points included:

Food safety supervision is a direct compliance area for foreign food and beverage companies. Wellness, fitness and preventive-health businesses may find a supportive policy narrative, but should not assume specific incentives.

Service Delivery, Traditional Medicine and the Health Industry

The conference identified raising the overall level of medical services as a key task. Stated measures include:

The explicit mention of "making the health industry bigger and stronger" is a notable signal for investors. Still, the source provides no details on foreign investment access, licensing timelines or incentives.

Reform of Medical, Insurance and Pharmaceutical Linkages

Reform was described as a powerful driver. The main direction is coordinated development and governance of medical services, medical insurance and pharmaceuticals. Specific points included:

For pharmaceutical and device companies, centralized procurement and drug quality supervision are established operational realities in China. Founders should build pricing and compliance strategies around them.

Talent, Professional Standards and International Cooperation

The conference called for strengthening the leadership and talent ranks of health institutions, building a medical workforce of sufficient size and quality, improving medical ethics, and fostering public respect for health workers.

On international engagement, Xi said health for all is a shared human aspiration and called for building a global community for health, joint responses to major challenges, deeper Belt and Road cooperation in health, innovation in foreign health assistance, and better communication of China's health story.

Premier Li Qiang's concluding remarks stressed implementing the speech, maintaining the health-first orientation, preserving the public-interest nature of basic medical services, balancing basic provision with quality improvement, and deepening reform, innovation and opening-up cooperation. He highlighted major disease control, tiered diagnosis and treatment, patient experience, multi-tiered insurance, traditional medicine, services for the elderly and children, and technology-enabled development.

Practical Takeaways for Foreign Founders

The conference did not announce specific market-access rules, tax measures or licensing changes for foreign investors. Founders should treat it as directional guidance and verify all requirements with qualified local advisers.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

Talk to us

WhatsApp / WeChat: +86 153 1898 8535

General information only, not legal or tax advice.